Magazine on Mastitis and Milk quality for the dairy professional
Ubrolexin®, a combination of kanamycin and cefalexin has been marketed for the intramammary treatment of clinical mastitis in lactating dairy cows in 27 countries by Boehringer-Ingelheim since 2008. The combination …
Read more
Twenty-three countries were represented at the 59th National Mastitis Council (NMC) Annual Meeting, held January 28-31 (2020), in Orlando, Florida, USA. International attendees accounted for 31 percent of the attendees.
Read more
When I arrived at the University of Minnesota in 1998 as a newly minted assistant professor, I had then only… This content is for M²-DIGITAL, M²-PREMIUM, M²-INSTITUTIONAL & NMC members …
Read more
Milk quality has evolved over the last several decades from a focus on control of contagious pathogens through improvements in milking technique and blanket dry cow treatment addressing the challenges …
Read more
Merial is now part of the Boehringer Ingelheim family. We have united the strengths of two leading players in animal health into ONE business unit within Boehringer Ingelheim.
Read more
‘The benefit of extended therapy for mastitis, myth or fact?’ was the topic at the third global milk quality expert forum,
Read more
As part of the Ubrocare program for the mastitis prevention and treatment, Boehringer Ingelheim has recently launched Ubrocare.com. This is… This content is for M²-DIGITAL, M²-PREMIUM, M²-INSTITUTIONAL & NMC members …
Read more
Trends in herd udder health and risk factors can be identified by monitoring the trends of individual cow cell counts.… This content is for M²-DIGITAL, M²-PREMIUM, M²-INSTITUTIONAL & NMC members …
Read more
Boehringer Ingelheim’s second Quality Milk Expert Forum entitled ‘What is the future of dry cow therapy?’
Read more
The Global Milk Quality Expert Forum is a group of independent experts from academia and practice facilitated by Boehringer Ingelheim’s… This content is for M²-DIGITAL, M²-PREMIUM, M²-INSTITUTIONAL & NMC members …
Read more